A cross-sectional study of 216 hospitalized patients found that lower effective atomic number in carotid plaque was ...
Gerasimovski's promise has not yet been fulfilled: parents are still waiting for students to pay a thousand less for their ...
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced that new clinical, biomarker, and ...
EQS-News: Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 – the 10th Joint ACTRIMS-ECTRIMS Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results